Desq Long
Sign in

Company

Mirum Pharmaceuticals, Inc.

MIRM · CIK 0001759425

SEC FORM 4
$978,092.91

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 9,943 shares at $98.37 per share.

Reporting Person BJERKHOLT ERIC · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001197350-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
—

Mirum Pharmaceuticals, Inc. (MIRM)

Acquisition (code M) of 18,333 shares; price not stated (see filing).

Reporting Person BJERKHOLT ERIC · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001197350-26-000010 · filed 2026-09-15 · View filing →

SEC FORM 4
$65,800.00

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 658 shares at $100 per share.

Reporting Person Howe Jolanda · Officer Title SVP, GLOBAL CONTROLLER · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001974200-26-000013 · filed 2026-09-03 · View filing →

SEC FORM 4
$88,080.00

Mirum Pharmaceuticals, Inc. (MIRM)

Acquisition (code M) of 30,000 shares at $2.936 per share.

Reporting Person Peetz Christopher · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001614740-26-000013 · filed 2026-09-03 · View filing →

SEC FORM 4
$815,240.96

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 8,312 shares at $98.08 per share.

Reporting Person Peetz Christopher · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001614740-26-000013 · filed 2026-09-03 · View filing →

SEC FORM 4
$2,145,160.08

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 21,688 shares at $98.91 per share.

Reporting Person Peetz Christopher · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001614740-26-000013 · filed 2026-09-03 · View filing →

SEC FORM 4
$250,800.00

Mirum Pharmaceuticals, Inc. (MIRM)

Acquisition (code M) of 40,000 shares at $6.27 per share.

Reporting Person Howe Jolanda · Officer Title SVP, GLOBAL CONTROLLER · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001974200-26-000012 · filed 2026-08-19 · View filing →

SEC FORM 4
$4,000,000.00

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 40,000 shares at $100 per share.

Reporting Person Howe Jolanda · Officer Title SVP, GLOBAL CONTROLLER · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001974200-26-000012 · filed 2026-08-19 · View filing →

SEC FORM 4
$599,509.50

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 6,001 shares at $99.9016 per share.

Reporting Person BJERKHOLT ERIC · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001197350-26-000009 · filed 2026-08-12 · View filing →